Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Nov;183(11):5053-5061.
doi: 10.1007/s00431-024-05776-0. Epub 2024 Sep 26.

Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis

Affiliations
Practice Guideline

Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis

Daniele Giovanni Ghiglioni et al. Eur J Pediatr. 2024 Nov.

Abstract

Vernal keratoconjunctivitis (VKC) is a chronic, recurrent, inflammatory disease that affects both eyes, often with asymmetric severity, potentially causing major visual complications. The seasonal management of VKC can be challenging, especially when specialists with different diagnostic and therapeutic approaches need to be consulted. The aim of this expert panel was to reach a national consensus among pediatric allergologists and ophthalmologists on the diagnosis and treatment of VKC. This consensus was developed by an expert panel of 17 Italian pediatric allergologists and ophthalmologists with over a decade of experience. Ten statements on VKC diagnosis and treatment formulated after a thorough review of current literature were evaluated by the panelists. The level of agreement was quantitatively assessed using a 5-point Likert scale. Consensus was reached if ≥ 75.0% of panelists agreed to any given statement. The consensus emphasizes the importance of evaluation by multispecialty reference centers or experienced specialists for accurate diagnosis. Prompt diagnosis, especially during active phases, is crucial and should occur before corticosteroid therapy. The Bonini score from 2007 is the preferred tool for VKC assessment, although future revisions may be considered. Short cycles of topical corticosteroids should be preferred over prolonged use, even during immunomodulatory therapy. When cyclosporine fails, tacrolimus should be considered.

Conclusion: This is the first consensus on the management of VKC that has gathered the expert opinions of both pediatricians and ophthalmologists. The outcome of this multidisciplinary effort provides a uniform approach to VKC diagnosis and treatment, thereby facilitating patient management across the country.

What is known: • Vernal keratoconjunctivitis (VKC) is a chronic recurrent ocular disease particularly prevalent in the pediatric population. • Despite its relevance, there is a lack of standardized approaches shared between pediatricians and ophthalmologists, leading to notable variations in clinical practice.

What is new: • This expert panel, comprising 17 pediatric allergologists and ophthalmologists, has reached a national consensus to provide standardized guidance for VKC management. • The consensus emphasizes the importance of a multidisciplinary approach to managing VKC, ensuring consistent and effective patient care.

Keywords: Consensus; Ocular allergy; VKC; Vernal keratoconjunctivitis.

PubMed Disclaimer

Conflict of interest statement

Daniele G. Ghiglioni, Gaia Bruschi, Elena Chiappini, Alessandra Consales, Pia Allegri, Pasquale Aragona, Stefano Bonini, Fabio Cardinale, Massimo Landi, Gian Luigi Marseglia, Francesca Mori, Marcella Nebbioso, Paolo Nucci, Silvia Osnaghi, Ugo Procoli, Edoardo Villani, Anna Maria Zicari, Michele Miraglia Del Giudice declare no conflict of interest. Roberto Caputo declares conflict of interest with Medivis, Alfa Intes and Santen. Andrea Leonardi declares the following financial interests or relationships: Alcon Laboratories, Inc.: Lecture Fees; Astra Zeneca: Consultant/Advisor; Faes Farma: Consultant/Advisor, Lecture Fees/Speakers Bureau; Fidia: Lecture Fees; NexEos: Consultant; Santen, Inc.: Consultant/Advisor, Lecture Fees/Speakers Bureau; Seqirus: Lecture Fees; SIFI: Lecture Fees; THEA: Consultant/Advisor; URSA Pharma: Lecture Fees.

Figures

Fig. 1
Fig. 1
Relative roles of the primary care physician/pediatrician, ophthalmologist, and multispecialty reference center in the management of VKC
Fig. 2
Fig. 2
Therapeutic management of VKC as discussed and agreed upon by the expert panel members

Similar articles

Cited by

References

    1. Bonini S, Bonini S, Lambiase A et al (2000) Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 107:1157–1163. 10.1016/s0161-6420(00)00092-0 - PubMed
    1. Bremond-Gignac D, Donadieu J, Leonardi A et al (2008) Prevalence of vernal keratoconjunctivitis: a rare disease? Br J Ophthalmol 92:1097–1102. 10.1136/bjo.2007.117812 - PubMed
    1. Montan PG, Ekström K, Hedlin G et al (1999) Vernal keratoconjunctivitis in a Stockholm ophthalmic centre–epidemiological, functional, and immunologic investigations. Acta Ophthalmol Scand 77:559–563. 10.1034/j.1600-0420.1999.770516.x - PubMed
    1. Leonardi A, Busca F, Motterle L et al (2006) Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol Scand 84:406–410. 10.1111/j.1600-0420.2005.00622.x - PubMed
    1. Kumar S (2009) Vernal keratoconjunctivitis: a major review. Acta Ophthalmol 87:133–147. 10.1111/j.1755-3768.2008.01347.x - PubMed

Publication types

Substances